首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2064995篇
  免费   210337篇
  国内免费   2014篇
  2277346篇
  2018年   20978篇
  2017年   19646篇
  2016年   30910篇
  2015年   45074篇
  2014年   53375篇
  2013年   79778篇
  2012年   63400篇
  2011年   57631篇
  2010年   52680篇
  2009年   51240篇
  2008年   52159篇
  2007年   52119篇
  2006年   52364篇
  2005年   52869篇
  2004年   51921篇
  2003年   48838篇
  2002年   46449篇
  2001年   72249篇
  2000年   70867篇
  1999年   60349篇
  1998年   30589篇
  1997年   30434篇
  1996年   29147篇
  1995年   27350篇
  1994年   26857篇
  1993年   26514篇
  1992年   51146篇
  1991年   49238篇
  1990年   47888篇
  1989年   47729篇
  1988年   44119篇
  1987年   42279篇
  1986年   39625篇
  1985年   40877篇
  1984年   36478篇
  1983年   31758篇
  1982年   27877篇
  1981年   26049篇
  1980年   24436篇
  1979年   33586篇
  1978年   28335篇
  1977年   26404篇
  1976年   24964篇
  1975年   26029篇
  1974年   27828篇
  1973年   27793篇
  1972年   24522篇
  1971年   22650篇
  1970年   19719篇
  1969年   19196篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
We have identified mouse and human FKBP60, a new member of the FKBP gene family. FKBP60 shares strongest homology with FKBP65 and SMAP. FKBP60 contains a hydrophobic signal peptide at the N-terminus, 4 peptidyl-prolyl cis/trans isomerase (PPIase) domains and an endoplasmic reticulum retention motif (HDEL) at the C-terminus. Immunodetection of HA-tagged FKBP60 in NIH-3T3 cells suggests that FKBP60 is segregated to the endoplasmic reticulum. Northern blot analysis shows that FKBP60 is predominantly expressed in heart, skeletal muscle, lung, liver and kidney. With N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide as a substrate, recombinant GST-FKBP60 is shown to accelerate effectively the isomerization of the peptidyl-prolyl bond. This isomerization activity is inhibited by FK506. mFKBP60 binds Ca2+ in vitro, presumably by its C-terminal EF-hand Ca2+ binding motif, and is phosphorylated in vivo. hFKBP60 has been mapped to 7p12 and/or 7p14 by fluorescence in situ hybridization (FISH).  相似文献   
3.
4.
Squilla mantis hemocyanin is composed of two hexameric subunits but has electron microscopic profiles different from other bis-hexameric hemocyanins, e.g. Astacus and Homarus. We distinguished three different electron microscopic profiles of S. mantis hemocyanin: two sideviews and a topview. These profiles were studied using computer image alignment and correspondence analysis [Van Heel, M. and Frank, J. (1981) Ultramicroscopy 6, 187 - 194]. With the results of this analysis we were able to build a three-dimensional model for the quaternary structure of this hemocyanin. In this model the two hexamers are stacked in such a way that their hexagonal surfaces overlap to about 60% of their width. In the overlap area four subunits are arranged in two different interhexameric pairs, each forming a bridging area between the two hexamers.  相似文献   
5.
6.
7.
A patient with chronic anemia is presented who radiologically showed prominent rugae of the stomach. Angiography demonstrated an arteriovenous malformation with a large feeding artery and prominent draining veins.  相似文献   
8.
9.
10.
Conventional therapies for prostate cancer, especially in its androgen-independent form, may result in the survival of small populations of resistant cells with tumor-initiating potential. These “cancer stem cells” are believed to be responsible for cancer relapse, and therapeutic strategies targeting these cells are of great importance. Telomerase is a ribonucleoprotein enzyme responsible for telomere elongation and is activated in the majority of malignancies, including prostate cancer, but is absent in most normal cells. Putative tumor-initiating cells have significant levels of telomerase, indicating that they are an excellent target for telomerase inhibition therapy. In this review, we present some evidence for the hypothesis that conventional therapies (standard chemotherapy and/or radiation therapy) in combination with telomerase inhibitors may result in effective and more durable responses.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号